What are the factors driving the interventional cardiology devices market?

Key factors that are driving the market growth include the rising prevalence of cardiovascular diseases, increased demand for minimally invasive procedures, and advancements in technologies such as drug-eluting stents and bioresorbable vascular scaffolds.

Who are the key players in interventional cardiology devices market?

Some key players operating in the interventional cardiology devices market include Abbott; Medtronic; Boston Scientific Corporation; Cardinal Health, Inc.; Koninklijke Philips N.V.; Terumo Corporation; Alvimedica Medical Technologies Inc.; Teleflex Incorporated; B. Braun Melsungen AG; Biosensors International Group, Ltd.; Meril Life Sciences Pvt. Ltd.; BIOTRONIK SE & Co. KG; ACIST Medical Systems, Inc.; Asahi Intecc Co., Ltd.; Cook Medical LLC; Medinol Ltd.; Merit Medical Systems, Inc.; NuMED, Inc.; OpSens Inc.; Zeon Medical Inc.; The Spectranetics Corporation; CID S.p.A.; Vascular Solutions, Inc.

How big is the interventional cardiology devices market?

The global interventional cardiology devices market size was estimated at USD 11.3 billion in 2025 and is expected to reach USD 12.1 billion in 2026.

What is the interventional cardiology devices market growth?

The global interventional cardiology devices market is expected to grow at a compound annual growth rate of 7.3% from 2026 to 2033 to reach USD 19.8 billion by 2033.

Which segment accounted for the largest interventional cardiology devices market share?

Coronary stents held a significant share in the industry in 2025 with a revenue share of 48.3% due to the high prevalence of coronary artery disease, widespread use of stents in percutaneous coronary interventions, and continued advancements in stent technology, including drug-eluting and bioresorbable stents.